Posts by: Sara Guariglia

Sara Guariglia

October 20, 2020October 20, 2020

Phase 1 Trial of SL-172154 in Treating Advanced Ovarian Cancer Opens

News

Shattuck Labs has opened a Phase 1 clinical trial to investigate its lead candidate, SL-172154, in treating people with advanced ovarian cancer, the company announced in a press release. The ... Read more

Search for:

Recent Ovarian Posts

Zejula Now Available in UK as Maintenance Therapy for Advanced Ovarian Cancer

January 21, 2021
UV1 Triple Combo Maintenance Therapy Will Be Tested in Phase 2 Trial

January 19, 2021
GPS Vaccine-Keytruda Combo Showing Efficacy in Advanced Cancer Patients

January 14, 2021

Ovarian Cancer News Today

BioNews Services, LLC

3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

Subscription Support
Publishing Team
Leadership
Our Values
Corrections Policy
Contact Us
Terms of Service
Privacy Policy

Disclaimer:

Ovarian Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

We use cookies to enhance your experience on our website. Privacy Policy Accept